A detailed history of Summit Financial Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Summit Financial Group, Inc. holds 3,654 shares of NVS stock, worth $359,736. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,654
Previous 3,654 -0.0%
Holding current value
$359,736
Previous $368,000 4.08%
% of portfolio
0.13%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023

SELL
$94.73 - $105.13 $3,789 - $4,205
-40 Reduced 1.08%
3,654 $372,000
Q1 2022

Apr 08, 2022

SELL
$80.11 - $90.62 $6,008 - $6,796
-75 Reduced 1.99%
3,694 $324,000
Q1 2021

Apr 07, 2021

SELL
$83.5 - $98.47 $668 - $787
-8 Reduced 0.21%
3,769 $322,000
Q3 2020

Oct 05, 2020

SELL
$82.14 - $91.0 $4,024 - $4,459
-49 Reduced 1.28%
3,777 $328,000
Q3 2019

Oct 09, 2019

SELL
$85.54 - $94.26 $51,324 - $56,556
-600 Reduced 13.56%
3,826 $332,000
Q1 2018

Apr 04, 2018

BUY
$70.39 - $84.15 $311,546 - $372,447
4,426 New
4,426 $358,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Summit Financial Group, Inc. Portfolio

Follow Summit Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.